About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Veyonda ®
Clinical Trials
IONIC
Other Trials
DARRT
CEP
LuPIN
NOXCOVID
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
Presentations & Interviews
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Presentations & Interviews
Filter by Year:
2023
2022
2021
2020
2019
2018
2017
2016
9-Dec-2020
Noxopharm Limited (ASX:NOX) CEO and Managing Director Dr Graham Kelly gives an update on the company and its clinical trials.
8-Dec-2020
Noxopharm Corporate Presentation December Investor Webinar
7-Dec-2020
The Market Herald Deal Room Interview with Noxopharm CEO and Managing Director Dr Graham Kelly
2-Dec-2020
Switzer Small & Micro Cap Virtual Investor Day 2020
17-Nov-2020
Noxopharm 2020 AGM Corporate Update
13-Nov-2020
CEO Dr Graham Kelly discusses the announcement of independent validation of Noxopharm's DARRT cancer therapy with TCN TV
9-Oct-2020
Noxopharm CMO discusses first patient treated in NOXCOVID trial
21-Sep-2020
Noxopharm Corporate Presentation September 2020
19-Aug-2020
Pitt Street Research Noxopharm CEO interview August 2020
14-Aug-2020
Noxopharm August 2020 EGM Corporate Presentation
1
2
Next
